By considering factors such as age, lifestyle, and specific health conditions, healthcare providers can develop customized protocols that enhance the effectiveness of these therapies
This BRAND is not yet available in India
Key takeaways Wegovy, an injectable weight-loss drug, helps reduce hunger and food intake by mimicking the hormone GLP-1
Studies in both humans and mice have shown that long-chain free fatty acids (LCFAs) increase GLP-1 secretion from taste cells, further reinforcing sucrose preference in a GLP-1 receptor-dependent manner (63, 64)
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy , 16 , 161173
Secondary endpoints: Mean change in body weight from baseline at Week 30